- “These innovations bring with them the opportunity for real-time assessment of behaviour and cognition, which are important among individuals with schizophrenia where the risk of relapse is ever-present yet remains challenging to identify6” (Henson, 2020, p. 1) - [[Article - Towards Clinically Actionable Digital Phenotyping Targets in Schizophrenia]]